Literature DB >> 2004920

Comparison of normal saline and heparin solutions for maintenance of arterial catheter patency.

G D Clifton1, P Branson, H J Kelly, L R Dotson, K E Record, B A Phillips, J R Thompson.   

Abstract

A double-blind, randomized study was conducted in 30 adult medical intensive care unit patients to determine if the presence of heparin in continuous-flush solutions prolongs the functional life span of radial arterial catheters compared with catheters flushed with solutions not containing heparin. Patients were consecutively entered into the study and randomly assigned to receive arterial line flush solutions containing 0.9% sodium chloride (NSS) or heparin 4 U/ml in 0.9% sodium chloride. The flow rate of each flush solution was approximately 3 ml/hr. Use of the heparin-containing flush solution resulted in a catheter survival rate of 86% at 96 hours compared with a rate of only 52% after 40 hours with NSS (p less than 0.05). In addition, the heparin-flushed catheters required significantly less manipulation to prevent catheter occlusion and arterial pressure-wave dampening (p less than 0.01). The use of NSS as a continuous flush for radial artery catheters is associated with an increased frequency of catheter occlusion and malfunctions compared with solution containing heparin, and thus is not recommended in patients with normal coagulation status and platelet count.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004920

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  8 in total

1.  Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials.

Authors:  A G Randolph; D J Cook; C A Gonzales; M Andrew
Journal:  BMJ       Date:  1998-03-28

Review 2.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2022-07-18

3.  Comparison between the effects of normal saline with and without heparin for the prevention and management of arterial catheter occlusion: a triple-blinded randomized trial.

Authors:  Takahiro Tamura; Eri Kobayashi; Mariko Kawaguchi; Yuki Matsuoka; Akiko Fujii; Masahiko Ando; Yoko Kubo; Takahiro Imaizumi; Yasuhiro Miyagawa; Takayuki Inagaki; Kimitoshi Nishiwaki
Journal:  J Anesth       Date:  2021-05-27       Impact factor: 2.078

4.  Impact of intravascular thrombosis on failure of radial arterial catheters in critically ill patients: a nested case-control study.

Authors:  Yvan Fleury; Diego Arroyo; Caroline Couchepin; Helia Robert-Ebadi; Marc Righini; Johannes A Lobrinus; Bara Ricou; Nathalie Delieuvin Schmitt; Angèle Gayet-Ageron
Journal:  Intensive Care Med       Date:  2018-04-02       Impact factor: 17.440

Review 5.  Heparin versus normal saline for patency of arterial lines.

Authors:  Suzanne Robertson-Malt; Greg N Malt; Vincent Farquhar; William Greer
Journal:  Cochrane Database Syst Rev       Date:  2014-05-13

6.  Heparinized solution vs. saline solution in the maintenance of arterial catheters: a double blind randomized clinical trial.

Authors:  Mercedes Del Cotillo; Núria Grané; Maria Llavoré; Salvador Quintana
Journal:  Intensive Care Med       Date:  2007-10-16       Impact factor: 17.440

7.  Impact of heparin and short term anesthesia on the quantification of cytokines in laboratory mouse plasma.

Authors:  Anne C Teilmann; Otto Kalliokoski; Kirsten R Jacobsen; Jann Hau; Klas S P Abelson
Journal:  Acta Vet Scand       Date:  2014-05-20       Impact factor: 1.695

Review 8.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis; Amanda Burls
Journal:  Cochrane Database Syst Rev       Date:  2018-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.